Unknown

Dataset Information

0

Ki-67 response-guided preoperative chemotherapy for HER2-positive breast cancer: results of a randomised Phase 2 study.


ABSTRACT:

Background

The effectiveness of a therapeutic strategy that switches chemotherapy, based on Ki-67 tumour expression after initial therapy, relative to that of standard chemotherapy, has not been evaluated.

Methods

Patients were randomly assigned to the control arm or the Ki-67 response-guided arm (Ki-67 arm). Primary tumour biopsies were obtained before treatment, and after three once-weekly doses of paclitaxel and trastuzumab to assess the interim Ki-67 index. In the control arm, paclitaxel and trastuzumab were continued for a total of 12 doses, regardless of the interim Ki-67 index. In the Ki-67 arm, subsequent treatment was based on the interim Ki-67 index. Ki-67 early responder is defined as the absolute Ki-67 value that was <10%, and the percentage of Ki-67-positive tumour cells was reduced by >30% compared with before treatment. Early Ki-67 responders continued to receive the same treatment, while early Ki-67 non-responders were switched to epirubicin plus cyclophosphamide. The primary endpoint was the pathological complete response (pCR) rate.

Results

A total of 237 patients were randomised. There was almost linear correlation between the Ki-67 reduction rate at interim assessment and the pCR rate. The pCR rate in Ki-67 early non-responders in the Ki-67 arm was inferior to that in the control arm (44.1%; 31.4-56.7; P = 0.025).

Conclusions

The standard chemotherapy protocol remains as the recommended strategy for patients with HER2-positive breast cancer.

Clinical trial registration

Clinical Trial Registration: UMIN-CTR as UMIN000007074.

SUBMITTER: Mukai H 

PROVIDER: S-EPMC7283228 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC8629999 | biostudies-literature
| S-EPMC9293341 | biostudies-literature
| S-EPMC8576677 | biostudies-literature
| S-EPMC6949686 | biostudies-literature
| S-EPMC7566118 | biostudies-literature
| S-EPMC4304382 | biostudies-literature
| S-EPMC8354752 | biostudies-literature
| S-EPMC4841783 | biostudies-literature
| S-EPMC6439556 | biostudies-literature
| S-EPMC6994569 | biostudies-literature